Very lightweight argument based on revenue and projected revenue and comparison with peers. No mention of science, test results or markets.
His expertise is quoted as being central banking and he is a self taught investor. His methodology probably works for mature businesses.
I seriously doubt he has us right.
- Forums
- ASX - By Stock
- Simply Wall Street article -> Should you buy Starpharma
Very lightweight argument based on revenue and projected revenue...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.00M |
Open | High | Low | Value | Volume |
9.8¢ | 10.5¢ | 9.6¢ | $210.8K | 2.098M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30408 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 3523 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30408 | 0.095 |
2 | 15638 | 0.094 |
3 | 83394 | 0.093 |
2 | 108435 | 0.091 |
2 | 41000 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 3523 | 2 |
0.105 | 119848 | 4 |
0.110 | 114099 | 6 |
0.115 | 77331 | 6 |
0.120 | 89055 | 5 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |